Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors.
Bioorg Chem
; 138: 106597, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-37245245
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Berberine
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Bioorg Chem
Year:
2023
Document type:
Article
Country of publication:
United States